Cerebral aneurysms are focal dilations of cerebral arteries that are present in approximately 3-5% of the general population. These lesions can rupture, resulting in subarachnoid hemorrhage, which has a near 50% mortality and morbidity rate. There are currently no medical therapies available, and cerebral aneurysms are managed via open surgical or endovascular approaches. It is thought that cerebral aneurysms are sporadic lesions caused by a combination of inflammation and hemodynamic stress, but standard anti-inflammatory agents increase the risk of hemorrhage and are not routinely used.